Konieczny MJ, Omarov M, Zhang L, et al. The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases. Communications biology. 2025;8(1):34. doi:10.1038/s42003-025-07453-w
Publications
Konieczny MJ, Omarov M, Zhang L, et al. The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases. Communications biology. 2025;8(1):34. doi:10.1038/s42003-025-07453-w
Konieczny MJ, Omarov M, Zhang L, et al. The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases. Communications biology. 2025;8(1):34. doi:10.1038/s42003-025-07453-w
Coley K, Wang Q, Packer R, et al. Genome-wide association study of varenicline-aided smoking cessation. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2025. doi:10.1093/ntr/ntaf009
Coley K, Wang Q, Packer R, et al. Genome-wide association study of varenicline-aided smoking cessation. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2025. doi:10.1093/ntr/ntaf009
Coley K, Wang Q, Packer R, et al. Genome-wide association study of varenicline-aided smoking cessation. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2025. doi:10.1093/ntr/ntaf009
Rabe DC, Choudhury A, Lee D, et al. Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture. Science advances. 2025;11(2):eadh1167. doi:10.1126/sciadv.adh1167
Rabe DC, Choudhury A, Lee D, et al. Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture. Science advances. 2025;11(2):eadh1167. doi:10.1126/sciadv.adh1167
Rabe DC, Choudhury A, Lee D, et al. Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture. Science advances. 2025;11(2):eadh1167. doi:10.1126/sciadv.adh1167
Furth N, Cohen N, Spitzer A, et al. Oncogenic IDH1 drives robust loss of histone acetylation and increases chromatin heterogeneity. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(1):e2403862122. doi:10.1073/pnas.2403862122